Global Point-of-Care Testing (POCT) Market is Expected At a CAGR 10.5% of During the Forecast Period 2022-2029
Data Bridge Market Research analyses that the point-of-care testing (POCT) market which was USD 29 billion in 2021, would rocket up
to USD 64.46 billion by 2029, and is
expected to undergo a CAGR of 10.5% during
the forecast period 2022 to 2029. In addition to the market insights such
as market value, growth rate, market segments, geographical coverage, market
players, and market scenario, the market report curated by the Data Bridge
Market Research team also includes in-depth expert analysis, patient
epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Get Your Sample Today: https://www.databridgemarketresearch.com/reports/point-care-testing-poct-market
Market Analysis and Insights
The
rising incidence rate of diabetes and obesity, the point of care testing market
for cardio metabolic testing is expected to surpass USD 5.3 billion by 2027.
The percentage level of Docosahexaenoic acid (DHA) and eicosapentanoic acid
(EPA) in red blood cell membrane is also determined by the cardiometabolic
test. This also aids in the identification of new risk factors for cardiac
arrest and other heart-related disorders. Point-of-care testing is defined as
testing that may be done in close proximity to the patient and allows a medical
choice to be taken immediately based on the results and monitoring.
Point-of-care testing (POCT), also known as with-patient testing, allows
doctors to assess accurate real-time, lab-quality diagnostic results in minutes
rather than hours. It guarantees that patients get the most effective and
efficient care possible, whenever and wherever they need it.
Buy Now Access Full Report:- https://www.databridgemarketresearch.com/reports/point-care-testing-poct-market
Global Point-of-Care Testing (POCT) Market Scope
· The point-of-care
testing (POCT) market is segmented on the basis of product, technology,
prescription, application, end-user and distribution channel. The growth
amongst these segments will help you analyze meagre growth segments in the
industries and provide the users with a valuable market overview and market
insights to help them make strategic decisions for identifying core market
applications.
Technology
· Lateral flow assays
· Dipsticks
· Microfluidics
· Molecular
diagnostics
· Immunoassays
· Agglutination assays
· Flow-through
· Solid phase
· Biosensors
Prescription
· OTC testing
· Prescription-based
testing
Application
· Cardio metabolic
testing
· Infectious disease
testing
· Nephrology testing
· Drug-of-Abuse (DoA)
testing
· Blood glucose
testing
· Pregnancy testing
· Cancer biomarker
testing
· Other applications
End-user
· Hospitals
· Diagnostic centers
· Research
laboratories
· Home-care settings
· Others
Distribution Channel
· Direct tender
· Retail Pharmacies
Global Point-of-Care Testing (POCT)
Market Country Level Analysis
The point-of-care testing (POCT) market also
provides you with detailed market analysis for every country growth in
healthcare expenditure for capital equipment, installed base of different kind
of products for point-of-care testing (POCT) market, impact of technology using
life line curves and changes in healthcare regulatory scenarios and their
impact on the point-of-care testing (POCT) market. The data is available for
historic period 2010-2020.
The
countries covered in the point-of-care testing (POCT) market report are U.S.,
Canada and Mexico in North America, Germany, France, U.K., Netherlands,
Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe,
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand,
Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC),
Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and
Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and
Rest of South America as part of South America.
Browse The Table of Contents And
List of Figures: https://www.databridgemarketresearch.com/toc/?dbmr=point-care-testing-poct-market
Major TOC of the Global
Point-of-Care Testing (POCT) Market Report
Chapter One:
MARKET
SEGEMENTATION
EXECUTIVE SUMMARY
PREMIUM INSIGHTS
MARKET
OVERVIEW
Competitive Landscape and Global
Point-of-Care Testing (POCT) Market Share Analysis
The point-of-care
testing (POCT) market competitive landscape provides details by competitor.
Details included are company overview, company financials, revenue generated,
market potential, investment in research and development, new market
initiatives, Asia-Pacific presence, production sites and facilities, production
capacities, company strengths and weaknesses, product launch, product width and
breadth, application dominance. The above data points provided are only related
to the companies' focus related to point-of-care testing (POCT) market.
Some of
the major players operating in the negative pressure wound therapy devices
market are
· Abbott (U.S.)
· F. Hoffmann-La
Roche Ltd (Switzerland)
· BD (U.S.)
· Siemens Healthcare
Private Limited (Germany)
· Bio-Rad Laboratories,
Inc. (U.S.)
· Danaher (U.S.)
· Sekisui Diagnostics
(U.S.)
· Trinity Biotech
(Ireland)
· bioMérieux (France)
· EKF Diagnostics
(Germany)
· AccuBioTech Co.,
Ltd. (China)
· Instrumentation
Laboratory (U.S.)
· Beckman Coulter,
Inc. (U.S.)
· PTS Diagnostics
(U.S.)
· Nova Biomedical
(U.S.)
· Chembio
Diagnostics, Inc. (U.S.)
· Quidel Corporation
(U.S.)
· Sienco, Inc (U.S.)
About
Us:
Data Bridge Market Research set
forth itself as an unconventional and neoteric Market research and consulting firm with
unparalleled level of resilience and integrated approaches. We are determined
to unearth the best Market opportunities and foster efficient information for
your business to thrive in the Market
Contact:
Data Bridge Market Research
Tel: +1-888-3895-2818
Email: Sopan.gedam@databridgeMarket
research.com
Browse Related Reports@
Comments
Post a Comment